It is used to treat a variety of conditions, including muscle damage, inflammation, and gastrointestinal disorders
Mice deficient in ABHD15 are unresponsive to the effects of insulin on lipolysis (122, 123)
In response, the medical community and compounding space shifted toward alternatives with a perceived improved safety profile: Ipamorelin a more selective growth hormone secretagogue CJC-1295 a growth hormone-releasing hormone (GHRH) analog These compounds were seen as a next generation option, offering many of the same benefits with potentially fewer side effects
What does BPC-157 research show for gastrointestinal conditions
Obesity-related health conditions, such as heart disease, stroke, diabetes, and certain cancers, are among the leading causes of preventable premature death